SGLT inhibitors in management of diabetes
We prioritize data reliability, controlled conditions, and the advancement of best practices in peptide reconstitution and compound stability, supporting precise and reproducible research outcomes
Depression There is emerging evidence that GLP-1 agonists may be directly beneficial in the treatment of depression, probably due to the interactions between the gut and the brain
Nat Gantz I et al (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
This is despite countless publications, finding an association between lower melatonin production in the mother, the fetus, or in the neonate, and the severity of symptoms in autism (Wiebe etal, 2018